BriaCell Therapeutics Corp. (BCTX): Operating Income
-$36.05M
Year ended 2026-07-31
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2026-07-31 | -$36.05M | n/m | 2026-10-28, From 2025-08-01 |
| 2025-07-31 | -$27.20M | n/m | 2026-10-28, From 2024-08-01 |
| 2024-07-31 | -$33.33M | n/m | 2025-10-16, From 2023-08-01 |
| 2023-07-31 | -$23.27M | n/m | 2024-10-29, From 2022-08-01 |
| 2022-07-31 | -$15.29M | n/m | 2023-10-25, From 2021-08-01 |
| 2021-07-31 | -$6.98M | n/a | 2022-10-28, From 2020-08-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| BriaCell Therapeutics Corp. (BCTX) | 2026-07-31 | -$36.05M | n/m |
| Immunic, Inc. (IMUX) | 2025-12-31 | -$103.23M | n/m |
| Rein Therapeutics, Inc. (RNTX) | 2025-12-31 | -$50.63M | n/m |
| Kiora Pharmaceuticals Inc (KPRX) | 2025-12-31 | -$12.83M | n/m |
| Faeth Therapeutics, Inc. (FTH) | 2025-12-31 | -$22.29M | n/m |
| CervoMed Inc. (CRVO) | 2025-12-31 | -$28.29M | n/m |
| Gain Therapeutics, Inc. (GANX) | 2025-12-31 | -$18.71M | n/m |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | -$13.16M | n/m |
| Onconetix, Inc. (ONCO) | 2025-12-31 | -$17.86M | n/m |
Compare BCTX, IMUX, RNTX, KPRX side by side · Screen every company in Pharmaceutical Preparations ↗